Xeris Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Xeris Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Xeris Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xeris Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.2M | 209k | 5.80 |
| 2025-12-31 | $1.4M | 174k | 7.85 |
| 2025-09-30 | $1.4M | 167k | 8.14 |
| 2025-06-30 | $716k | 153k | 4.67 |
| 2025-03-31 | $969k | 176k | 5.49 |
| 2024-12-31 | $578k | 171k | 3.39 |
| 2024-09-30 | $459k | 161k | 2.85 |
| 2024-06-30 | $295k | 131k | 2.25 |
| 2024-03-31 | $278k | 126k | 2.21 |
| 2023-12-31 | $271k | 115k | 2.36 |
| 2023-09-30 | $210k | 113k | 1.86 |
| 2023-06-30 | $290k | 110k | 2.63 |
| 2023-03-31 | $201k | 123k | 1.63 |
| 2022-12-31 | $164k | 123k | 1.33 |
| 2022-03-31 | $61k | 24k | 2.54 |
| 2021-12-31 | $37k | 13k | 2.91 |